Ezaladcigene resoparvovec

DB16795InvestigationalGene Therapies

Ezaladcigene resoparvovec: Overview.

Code names
NBIB-1817 · VY-AADC02

Resolves to

Compound
UNII2WRS0PE04OCAS2226647-27-2

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Ezaladcigene resoparvovec, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In